MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Telemedicine (TelePharmacy, ePrescribing) Companies)
LifeMD, Inc. (NASDAQ:LFMD), formerly, Conversion Labs (OTCQB:CVLB), formerly, Immudyne, Inc.
Organization & Developments: LifeMD
Parents
LifeMD, Inc. (NASDAQ:LFMD), formerly, Conversion Labs (OTCQB:CVLB), formerly, Immudyne, Inc.
Children
2020: Conversion Labs Offers A Big Opportunity Here
2021: Conversion Labs: Telehealth Subscriptions
2023: LifeMD Is The Stock To Play The Mega GLP-1 Drug Trend (NASDAQ:LFMD)
2023: LifeMD: Medifast Partnership Further Validates Weight Management Program_seekingalpha.com
2023: LifeMD's Revival: The Phoenix Of The Health Industry
2024: LifeMD, Inc.'s (NASDAQ:LFMD) top owners are retail investors with 45% stake, while 38% is held by institutions
2024: LifeMD: A Story I Want A Small Piece Of
2024: LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program
2024: LifeMD: Selling WorkSimpli Could Be A Catalyst
2024: LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability_ seekingalpha.com
2024: LifeMD® Launches Affiliated Pharmacy to Drive End-to-End
2024: LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer
2025: Eli Lilly expands telehealth access to low-cost Zepbound with Teladoc Health, LifeMD tie-ups
2025: LifeMD Might Run Higher
2025: LifeMD: Dilution Ramps Up As Revenue Moves Higher
2025: LifeMD: Growth, Growth, And More Growth
2025: Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers
Jumps
Finance & Acquisitions: LifeMD
Key People: LifeMD